Zydus Receives US FDA Priority Review for Saroglitazar NDA in Primary Biliary Cholangitis Treatment 28/05/2026 / Business Updates / Regulatory Development Zydus Receives US FDA Priority Review for Saroglitazar NDA in Primary Biliary Cholangitis Treatment Read Post ยป
